Melanie Weatherley MBE

Lincolnshire Health and Wellbeing Board - Tuesday, 10th March, 2026 2.00 pm

The Lincolnshire Health and Wellbeing Board was scheduled to discuss a range of important health and social care matters, including the NHS Joint Forward Plan, an update on the Joint Strategic Needs Assessment, and the Lincolnshire Better Care Fund. The meeting agenda also included the Director of Public Health's annual report, focusing on the public health case for quality employment.

Adult Care and Public Health Scrutiny Committee - Friday, 27th February, 2026 10.00 am

The Adult Care and Public Health Scrutiny Committee was scheduled to consider several key reports concerning the provision of care services. These included a review of the usual costs for residential and residential with nursing care, an extension of the Direct Payment Support Service contract, and the future of the Mental Health and Wellbeing Community Investment Fund. Additionally, the committee was set to discuss the decommissioning of the Memory Support Service and a review of the Mental Health Section 75 National Health Service Act 2006 Agreement.

Lincolnshire Health and Wellbeing Board - Tuesday, 9th December, 2025 2.00 pm

This meeting has been cancelled.

Lincolnshire Health and Wellbeing Board - Tuesday, 23rd September, 2025 2.00 pm

The Lincolnshire Health and Wellbeing Board noted updates on the Joint Health and Wellbeing Strategy, the Better Care Fund, and health protection, and agreed to establish a working group to develop a neighbourhood plan. The board also thanked Dr Jerry McSorley, the retiring chair of the Lincolnshire Integrated Care Board (ICB), for his service.

Lincolnshire Health and Wellbeing Board - Tuesday, 24th June, 2025 2.00 pm

The Lincolnshire Health and Wellbeing Board met to review governance arrangements and approve a pharmaceutical needs assessment. Councillor S W Clegg, Executive Councillor for Adult Care and Public Health, was appointed chair, and Claire Raybold from NHS Lincolnshire Integrated Care Board (ICB) was appointed vice-chair. The board reaffirmed its terms of reference and approved associate membership for 2025-2026 and approved the final Pharmaceutical Needs Assessment for 2025.